$16.880
+0.132 (+0.78%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CARL Prediction & Forecast by Similar Chart Analysis
Alphio's CARL stock price prediction model matches the current Carlsmed, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $17.46 (+3.46%). The 1-week path is $17.30 (+2.49%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Carlsmed, Inc. Stock?
Carlsmed Inc is a good buy right now due to its strong revenue growth and improving gross margins. The current price is $16.88, and the company reported Q2 2026 revenue of $18.9 million, exceeding expectations by $0.95 million, indicating robust market performance. Additionally, the gross margin for Q2 2026 was 76.8%, up from 73.4% in Q2 2025, showcasing effective cost management. However, the main risk is the widening net loss of $10.5 million in Q2 2026, which is higher than the previous year's loss of $6.8 million, indicating ongoing financial pressures as the company expands.
CARL stock price ended at $16.88 on Friday, after rising +0.78%
Carlsmed, Inc. (CARL) last closed at $16.88, gaining +0.78%. These facts feed the 1-day and 1-week CARL price prediction above.
Forecast Drivers
Carlsmed, Inc. (CARL) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches CARL, ranked by similarity.
Seasonality analysis for CARL
Historically the probability of a positive August return for CARL is 48.78%. January offers the highest probability of a positive month at 95.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.